gypsogenin

Gypsogenin is a naturally occurring pentacyclic triterpenoid sapogenin primarily extracted from the roots of *Gypsophila* species, such as *Gypsophila oldhamiana*. It serves as a key scaffold in medicinal chemistry for the synthesis of various semisynthetic derivatives with enhanced biological activities. Gypsogenin and its derivatives have been widely investigated for their anti-cancer, anti-proliferative, and cytotoxic properties against multiple cancer cell lines, including breast cancer (MCF-7), cervical cancer (HeLa), and chronic myelogenous leukemia (K562). Its mechanism of action involves the induction of apoptosis, cell cycle arrest (particularly in the S phase), and the inhibition of key signaling pathways, including the down-regulation of pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) and growth factors (FGF-1). Additionally, certain gypsogenin derivatives have demonstrated inhibitory activity against ABL1 kinase and acetylcholinesterase.

Other names

3beta-hydroxy-23-oxoolean-12-en-28-oic acidalbasapogeninastrantiagenin Dgithageningypsophilasapogeningypsophilasaponinsaponin-gypsophila